Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
166.6 USD | +0.56% | +6.01% | -7.35% |
Sales 2024 * | 638M 872M | Sales 2025 * | 739M 1.01B | Capitalization | 9.3B 12.71B |
---|---|---|---|---|---|
Net income 2024 * | 43M 58.78M | Net income 2025 * | 88M 120M | EV / Sales 2024 * | 14.2 x |
Net cash position 2024 * | 276M 377M | Net cash position 2025 * | 386M 528M | EV / Sales 2025 * | 12.1 x |
P/E ratio 2024 * |
314
x | P/E ratio 2025 * |
112
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.41% |
Latest transcript on Repligen Corporation
1 day | +0.56% | ||
1 week | +6.01% | ||
Current month | -9.43% | ||
1 month | -9.83% | ||
3 months | -13.87% | ||
6 months | +39.30% | ||
Current year | -7.35% |
Managers | Title | Age | Since |
---|---|---|---|
Tony Hunt
CEO | Chief Executive Officer | 60 | 14-04-30 |
Olivier Loeillot
PSD | President | 54 | 23-10-01 |
Jason Garland
DFI | Director of Finance/CFO | 50 | 23-09-24 |
Members of the board | Title | Age | Since |
---|---|---|---|
Karen Dawes
CHM | Chairman | 72 | 05-08-31 |
Director/Board Member | 58 | 14-06-11 | |
Martin Madaus
BRD | Director/Board Member | 64 | 23-02-05 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.43% | 5 M€ | -1.80% | - | |
1.01% | 0 M€ | 0.00% | - | |
0.84% | 0 M€ | 0.00% | - | |
0.55% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 166.6 | +0.56% | 341,269 |
24-04-25 | 165.7 | -1.31% | 238,746 |
24-04-24 | 167.9 | -2.00% | 545,959 |
24-04-23 | 171.3 | +8.76% | 928,614 |
24-04-22 | 157.5 | +0.22% | 294,448 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.35% | 9.3B | |
-2.31% | 187B | |
-3.20% | 106B | |
-5.04% | 66.9B | |
+0.20% | 49.45B | |
+17.29% | 48B | |
+4.06% | 40.84B | |
+2.07% | 26.48B | |
+2.36% | 26.25B | |
+12.96% | 24.62B |
- Stock Market
- Equities
- RGEN Stock